Medications

Oral drug blocks SARS-CoV-2 transmission

Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State ...

Medical research

New study explains important cause of fatal influenza

It is largely unknown why influenza infections lead to an increased risk of bacterial pneumonia. Researchers at Karolinska Institutet have now described important findings leading to so-called superinfections, which claim ...

Diseases, Conditions, Syndromes

Common cold combats influenza

As the flu season approaches, a strained public health system may have a surprising ally—the common cold virus.

Diseases, Conditions, Syndromes

Study provides insight on how to build a better flu vaccine

Flu season comes around like clockwork every year, and sooner or later everyone gets infected. The annual flu shot is a key part of public health efforts to control the flu, but the vaccine's effectiveness is notoriously ...

Diseases, Conditions, Syndromes

Nasal vaccine against COVID-19 prevents infection in mice

Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible ...

Diseases, Conditions, Syndromes

Airborne viruses can spread on dust, non-respiratory particles

Influenza viruses can spread through the air on dust, fibers and other microscopic particles, according to new research from the University of California, Davis and the Icahn School of Medicine at Mt. Sinai. The findings, ...

page 9 from 40